REVMEDUAS
REVMEDUAS; Vol. 16 No. 2 Abril-Junio 2026
ISSN 3122-4342

1. Becaria del Servicio de Retina y vítreo del Centro de Investigación y Docencia en Ciencias de la Salud en el Hospital Civil de Culiacán de la Universidad Autónoma de Sinaloa, Culiacán, Sinaloa, México
2. Oftalmólogo y retinólogo del Servicio de Retina y vítreo del Centro de Investigación y Docencia en Ciencias de la Salud en el Hospital Civil de Culiacán de la Universidad Autónoma de Sinaloa, Culiacán, Sinaloa, México
3. Servicio de Retina y vítreo del Centro de Investigación y Docencia en Ciencias de la Salud en el Hospital Civil de Culiacán de la Universidad Autónoma de Sinaloa, Culiacán, Sinaloa, México
4. Doctor en Ciencias con orientación en probabilidad y estadística, Centro de Investigación y Docencia en Ciencias de la Salud, Culiacán, Sinaloa, México
5. Unidad de Investigación. Centro de Investigación y Docencia en Ciencias de la Salud en el Hospital Civil de Culiacán de la Universidad Autónoma de Sinaloa, Culiacán, Sinaloa, México

*Autor de correspondencia: Dra. Estephanye Celina Miranda-Haro
Domicilio: Calle Eustaquio Buelna No. 91, Colonia Gabriel Leyva C.P. 80030 Culiacán, Sinaloa.
Tel. (667) 1025048 Correo: Stephanye_mh@hotmail.com.

DOI http://dx.doi.org/10.28960/revmeduas.3122-4342.v16.n2.004

Recibido 02 de diciembre 2025, aceptado 10 de septiembre 2025

RESUMEN
Objetivo: Determinar la concordancia en el diagnóstico de DMAE temprana e intermedia al utilizar imágenes de autofluorescencia de fondo de ojo de campo ultra amplio, obtenidas con sistema Mirante® respecto a las obtenidas con sistema Clarus 700®. Metodología: Se realizó un estudio observacional, descriptivo, prospectivo y transversal de tipo estudio de concordancia. Se incluyeron ojos de pacientes con presencia de drusas y con o sin diagnóstico ya establecido de DMAE, se hizo la toma de imágenes de fondo de ojo de campo ultra amplio con los sistemas Mirante® y Clarus 700® para la medición y posterior clasificación de la longitud de drusas mediante el sistema AREDS. Resultados: Se incluyeron 184 ojos, de acuerdo a la clasificación AREDS, la categoría AREDS 2 estuvo presente en 145 ojos (78.8%), seguida de la categoría AREDS 3, en 31 ojos (16.8%), finalmente la categoría AREDS 1 en 8 ojos (4.3%). Ambos equipos son concordantes en la clasificación AREDS de la DMAE, se obtuvo un coeficiente Kappa de Cohen de 1.000, lo cual corresponde a una concordancia perfecta y altamente significativa. Conclusiones: No existen diferencias en cuanto al uso de las cámaras de fondo de ojo de campo ultra amplio Mirante® y Clarus 700®, para la clasificación y estadificación de la DMAE temprana e intermedia. Ambos sistemas de imágenes fueron generalmente concordantes en la evaluación de la longitud de las drusas.
Palabras clave: DMAE, autofluorescencia, drusas, AREDS.

ABSTRACT
Objective: To determine the concordance in the diagnosis of early and intermediate AMD using ultra-widefield fundus autofluorescence images obtained with the Mirante® system compared to those obtained with the Clarus 700® system. Methodology: An observational, descriptive, prospective, cross-sectional study of the concordance type was conducted. Eyes of patients with the presence of drusen and with or without an established diagnosis of AMD were included. Ultra-widefield fundus images were taken with the Mirante® and Clarus 700® systems for the measurement and subsequent classification of drusen length using the AREDS system. Results: 184 eyes were included; according to the AREDS classification, AREDS category 2 was present in 145 eyes (78.8%), followed by AREDS category 3 in 31 eyes (16.8%), and finally AREDS category 1 in 8 eyes (4.3%). Both devices are concordant in the AREDS classification of AMD, a Cohen Kappa coefficient of 1.000 was obtained, which corresponds to a perfect and highly significant concordance. Conclusions: There are no differences regarding the use of the Mirante® and Clarus 700® ultra-widefield fundus cameras for the classification and staging of early and intermediate AMD. Both imaging systems were generally concordant in the evaluation of drusen length.
Keywords: AMD, autofluorescence, drusen, AREDS.

Referencias

1. Deng Y, Qiao L, Du M, Qu C, Wan L, Li J, et al. Age-related macular degeneration: Epidemiology, genetics, pathophysiology, diagnosis, and targeted therapy. Genes Dis. 2022;9(1):62–79.
2. Zając-Pytrus H, Pilecka A, Turno-Kręcicka A, Adamiec-Mroczek J, Misiuk-Hojło M. The dry form of age-related macular degeneration (AMD): The current concepts of pathogenesis and prospects for treatment. Adv Clin Exp Med. 2015;24(6):1099–104.
3. Wong WL, Su X, Li X, Cheung CMG, Klein R, Cheng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106–16.
4. Duisdieker V, Fleckenstein M, Zilkens KM, Steinberg JS, Holz FG, Schmitz-Valckenberg S. Long-term follow-up of fundus autofluorescence imaging using wide-field scanning laser ophthalmoscopy. Ophthalmol. 2015;234(4):218–26.
5. Holz FG, Steinberg JS, Göbel A, Fleckenstein M, Schmitz-Valckenberg S. Fundus autofluorescence imaging in dry AMD: 2014 Jules Gonin lecture of the Retina Research Foundation. Graefes Arch Clin Exp Ophthalmol. 2015;253:7–16
6. Wu Z, Luu CD, Ayton LN, Goh JK, Lucci LM, Hubbard WC, et al. Fundus autofluorescence characteristics of nascent geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2015;56(3):1546–52.
7. Rodríguez A, Biarnés M, Coco-Martin RM, Sala-Puigdollers A, Monés J. Early detection of incipient retinal pigment epithelium atrophy overlying drusen with fundus autofluorescence vs. Spectral domain optical coherence tomography. J Ophthalmol. 2020:1–8.
8. Landa G, Rosen RB, Pilavas J, Garcia PMT. Drusen characteristics revealed by spectral-domain optical coherence tomography and their corresponding fundus autofluorescence appearance in dry age-related macular degeneration. Ophthalmic Res. 2012;47(2):81–6.
9. Nandakumar N, Buzney S, Weiter JJ. Lipofuscin and the principles of fundus autofluorescence: A review. Semin Ophthalmol. 2012;27(5–6):197–201.
10. Patel SN, Shi A, Wibbelsman TD, Klufas MA. Ultra-widefield retinal imaging: an update on recent advances. Ther Adv Ophthalmol. 2020;12:25.
11. Guduru A, Fleischman D, Shin S, Zeng D, Baldwin JB, Houghton OM, et al. Ultra-widefield fundus autofluorescence in age-related macular degeneration. PLoS One. 2017;12(6):e0177207.
12. Schmitz-Valckenberg S, Holz FG, Bird AC, Spaide RF. Fundus autofluorescence imaging: Review and perspectives. Retina. 2008;28(3):385–409.
13. Schmitz-Valckenberg S, Fleckenstein M, Scholl HPN, Holz FG. Fundus autofluorescence and progression of age-related macular degeneration. Surv Ophthalmol. 2009;54(1):96–117.
14. Schmitz-Valckenberg S. Fundusautofluoreszenz-Imaging. Klin Monbl Augenheilkd. 2015;232(09):1050–3.
15. Şahinoğlu-Keşkek N, Şermet F. The use of fundus autofluorescence in dry age-related macular degeneration. Türk oftalmol derg. 2021;51(3):169–76.
16. Sadda SR, Guymer R, Holz FG, Schmitz-Valckenberg S, Curcio CA, Bird AC, et al. Consensus definition for atrophy associated with age-related macular degeneration on OCT. Ophthalmol. 2018;125(4):537–48.
17. Vidinova C, Gouguchkova P, Vidinov K. Fundusautofluoreszenz bei der trockenen Form der altersbedingten Makuladegeneration – Bedeutung für die Prognose. Klin Monbl Augenheilkd. 2013;230(11):1135–41.
18. Ly A, Nivison-Smith L, Assaad N, Kalloniatis M. Fundus autofluorescence in age-related macular degeneration. Optom Vis Sci. 2017;94(2):246–59.
19. Nivison-Smith L, Milston R, Madigan M, Kalloniatis M. Age-related macular degeneration: Linking clinical presentation to pathology. Optom Vis Sci. 2014;91(8):832–48.
20. Sastre-Ibáñez M, Barreiro-González A, Gallego-Pinazo R, Dolz-Marco R, García-Armendariz B. Atrofia geográfica: etiopatogenia y terapias actuales. Arch Soc Esp Oftalmol. 2018;93(1):22–34.
21. Xu A, Chen C. Clinical application of ultra-widefield fundus autofluorescence. Int Ophthalmol. 2021;41(2):727–41.
22. Smith RT, Chan JK, Busuoic M, Sivagnanavel V, Bird AC, Chong NV. Autofluorescence characteristics of early, atrophic, and high-risk fellow eyes in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2006;47(12):5495.
23. Ranetti AE, Stanca HT, Tăbăcaru B, Teodoru A, Munteanu M, Stanca S. Retromode imaging in age-related macular degeneration. Medicina (Kaunas). 2023;59(4):647.
24. Schmitz-Valckenberg S, Steinberg JS, Fleckenstein M, Visvalingam S, Brinkmann CK, Holz FG. Combined confocal scanning laser ophthalmoscopy and spectral-domain optical coherence tomography imaging of reticular drusen associated with age-related macular degeneration. Ophthalmol. 2010;117(6):1169–76.
25. Corradetti G, Byon I, Corvi F, Cozzi M, Staurenghi G, Sadda SR. Retro mode illumination for detecting and quantifying the area of geographic atrophy in non-neovascular age-related macular degeneration. EYE. 2022;36(8):1560–6.
26. Stino H, Riessland S, Sedova A, Datlinger F, Sacu S, Schmidt-Erfurth U,et al. Comparison of two ultra-widefield color-fundus imaging devices for visualization of retinal periphery and microvascular lesions in patients with early diabetic retinopathy. Sci Rep. 2022;12(1):17449.
27. Pole C, Ameri H. Fundus Autofluorescence and Clinical Applications. J Ophthalmic Vis Res 2021;16:432–461.
28. Reznicek L, Wasfy T, Stumpf C, Kampik A, Ulbig M, Neubauer AS, et al. Peripheral fundus autofluorescence is increased in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2012; 53(4):2193-8.
29. Domalpally A, Clemons TE, Danis RP, Sadda SR, Cukras CA, Toth CA, et. al. Peripheral Retinal Changes Associated with Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 12 by the Age-Related Eye Disease Study 2 Optos PEripheral RetinA (OPERA) Study Research Group. Ophthalmol. 2017; 124(4):479-487.
30. Guduru A, Fleischman D, Shin S, Zeng D, Baldwin JB, Houghton OM, et al. Ultra-widefield fundus autofluorescence in age-related macular degeneration. PLoS One. 2017;12(6):e0177207.
31. Tan CS, Heussen F, Sadda SR. Peripheral autofluorescence and clinical findings in neovascular and non- neovascular age-related macular degeneration. Ophthalmol. 2013; 120(6):1271-7.